ReposiTrak Inc. (NYSE:TRAK – Get Free Report) CEO Randall Fields sold 5,000 shares of the firm’s stock in a transaction dated Monday, January 5th. The stock was sold at an average price of $12.27, for a total transaction of $61,350.00. Following the completion of the sale, the chief executive officer directly owned 155,000 shares of the company’s stock, valued at approximately $1,901,850. The trade was a 3.13% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
ReposiTrak Stock Performance
Shares of ReposiTrak stock remained flat at $11.76 during trading on Wednesday. The stock had a trading volume of 60,791 shares, compared to its average volume of 84,048. ReposiTrak Inc. has a 1 year low of $11.51 and a 1 year high of $23.72. The stock has a market cap of $215.09 million, a price-to-earnings ratio of 32.67 and a beta of 0.41. The firm’s 50-day moving average is $13.67 and its two-hundred day moving average is $15.83.
ReposiTrak (NYSE:TRAK – Get Free Report) last issued its quarterly earnings results on Thursday, November 13th. The company reported $0.09 earnings per share (EPS) for the quarter. ReposiTrak had a return on equity of 14.37% and a net margin of 30.52%.The business had revenue of $5.97 million for the quarter.
Analyst Ratings Changes
Get Our Latest Stock Report on TRAK
Institutional Investors Weigh In On ReposiTrak
Several large investors have recently added to or reduced their stakes in TRAK. BNP Paribas Financial Markets lifted its holdings in ReposiTrak by 63.5% during the 2nd quarter. BNP Paribas Financial Markets now owns 1,633 shares of the company’s stock worth $32,000 after buying an additional 634 shares in the last quarter. Ingalls & Snyder LLC raised its stake in shares of ReposiTrak by 1.3% in the second quarter. Ingalls & Snyder LLC now owns 198,714 shares of the company’s stock valued at $3,905,000 after acquiring an additional 2,554 shares in the last quarter. Tower Research Capital LLC TRC boosted its holdings in ReposiTrak by 397.3% in the second quarter. Tower Research Capital LLC TRC now owns 3,620 shares of the company’s stock valued at $71,000 after purchasing an additional 2,892 shares during the period. Ellsworth Advisors LLC grew its stake in ReposiTrak by 10.6% during the 1st quarter. Ellsworth Advisors LLC now owns 31,289 shares of the company’s stock worth $634,000 after purchasing an additional 2,997 shares in the last quarter. Finally, Raymond James Financial Inc. raised its position in ReposiTrak by 22.5% in the 3rd quarter. Raymond James Financial Inc. now owns 17,359 shares of the company’s stock valued at $257,000 after purchasing an additional 3,185 shares in the last quarter. 27.35% of the stock is owned by hedge funds and other institutional investors.
ReposiTrak Company Profile
ReposiTrak, trading on the New York Stock Exchange under the symbol TRAK, is a provider of cloud-based supply chain compliance and transparency solutions. The company’s platform enables retailers, suppliers and manufacturers to manage, share and validate product data throughout the supply chain. Through its Software-as-a-Service (SaaS) offering, ReposiTrak helps organizations ensure adherence to regulatory requirements, industry standards and retailer-specific guidelines for food safety, sustainability, labeling and quality assurance.
At the core of ReposiTrak’s offerings is its DataHub, a centralized repository that captures critical information such as product specifications, certifications, catch-weight data, temperature logs and recall notifications.
See Also
- Five stocks we like better than ReposiTrak
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Do not delete, read immediately
- You Still Think Silver’s a Joke? Watch What Happens Next.
- This stock gets a 94 out of 100
- Punch these codes into your ordinary brokerage account
Receive News & Ratings for ReposiTrak Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReposiTrak and related companies with MarketBeat.com's FREE daily email newsletter.
